These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8626815)

  • 1. A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.
    Woods KA; Fraser NC; Postel-Vinay MC; Savage MO; Clark AJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1686-90. PubMed ID: 8626815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
    Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
    J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
    Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.
    Aisenberg J; Auyeung V; Pedro HF; Sugalski R; Chartoff A; Rothenberg R; Derr MA; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2010; 74(6):406-11. PubMed ID: 20606392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extreme elevation of serum growth hormone-binding protein concentrations resulting from a novel heterozygous splice site mutation of the growth hormone receptor gene.
    Aalbers AM; Chin D; Pratt KL; Little BM; Frank SJ; Hwa V; Rosenfeld RG
    Horm Res; 2009; 71(5):276-84. PubMed ID: 19339792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform.
    Pantel J; Grulich-Henn J; Bettendorf M; Strasburger CJ; Heinrich U; Amselem S
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1705-10. PubMed ID: 12679461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.
    Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V
    Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth hormone receptor gene mutation of a Japanese patient with Laron syndrome.
    Otsuka T; Iwatani N; Kodama M; Sakakida M; Shichiri M; Jinno Y; Niikawa N; Miike T
    Jpn J Hum Genet; 1997 Jun; 42(2):323-9. PubMed ID: 9290257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome.
    Berg MA; Guevara-Aguirre J; Rosenbloom AL; Rosenfeld RG; Francke U
    Hum Mutat; 1992; 1(1):24-32. PubMed ID: 1284474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nine novel growth hormone receptor gene mutations in patients with Laron syndrome.
    Sobrier ML; Dastot F; Duquesnoy P; Kandemir N; Yordam N; Goossens M; Amselem S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):435-7. PubMed ID: 9024232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome.
    Kaji H; Nose O; Tajiri H; Takahashi Y; Iida K; Takahashi T; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3705-9. PubMed ID: 9360529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
    Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein.
    Ross RJ; Esposito N; Shen XY; Von Laue S; Chew SL; Dobson PR; Postel-Vinay MC; Finidori J
    Mol Endocrinol; 1997 Mar; 11(3):265-73. PubMed ID: 9058373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of inherited growth hormone resistance in childhood.
    Amselem S; Sobrier ML; Dastot F; Duquesnoy P; Duriez B; Goossens M
    Baillieres Clin Endocrinol Metab; 1996 Jul; 10(3):353-69. PubMed ID: 8853444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration.
    Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):36-40. PubMed ID: 14678285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [GH receptor gene mutations and growth failure].
    Kaji H
    Nihon Rinsho; 1998 Jul; 56(7):1830-5. PubMed ID: 9702061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome.
    Freeth JS; Ayling RM; Whatmore AJ; Towner P; Price DA; Norman MR; Clayton PE
    Endocrinology; 1997 Jan; 138(1):55-61. PubMed ID: 8977385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.
    Goddard AD; Covello R; Luoh SM; Clackson T; Attie KM; Gesundheit N; Rundle AC; Wells JA; Carlsson LM
    N Engl J Med; 1995 Oct; 333(17):1093-8. PubMed ID: 7565946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids with alternative 5'-untranslated regions are differentially expressed in mouse liver and placenta.
    Southard JN; Barrett BA; Bikbulatova L; Ilkbahar Y; Wu K; Talamantes F
    Endocrinology; 1995 Jul; 136(7):2913-21. PubMed ID: 7789316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.